tafenoquine has been researched along with vinorelbine in 1 studies
| Studies (tafenoquine) | Trials (tafenoquine) | Recent Studies (post-2010) (tafenoquine) | Studies (vinorelbine) | Trials (vinorelbine) | Recent Studies (post-2010) (vinorelbine) |
|---|---|---|---|---|---|
| 186 | 37 | 113 | 50 | 0 | 31 |
| Protein | Taxonomy | tafenoquine (IC50) | vinorelbine (IC50) |
|---|---|---|---|
| Tubulin beta-4A chain | Homo sapiens (human) | 1.35 | |
| Cholinesterase | Homo sapiens (human) | 0.7 | |
| Tubulin beta chain | Homo sapiens (human) | 1.35 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 1 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 1.35 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.7 | |
| Substance-K receptor | Homo sapiens (human) | 1.6062 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.7 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.7 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 1.35 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 1.35 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 1.35 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 1.35 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 1.35 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
1 other study(ies) available for tafenoquine and vinorelbine
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |